Latest NewsNov 4, 2024HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200604, a Best-in-Class BTLA Agonist Antibody for the Treatment of Inflammatory and Immunology Diseases All Filter By: Year2024202320222021202020192018201720162015Nov 7, 2016HiFiBiO SAS to Present Advances in Functional Therapeutic Antibody Discovery with Two Talks at Human Antibodies and Hybridomas Conference to Be Held in Belfast, Northern Ireland, Wednesday, November 9, 2016May 26, 2016HiFiBiO receives recognition as one of Biocentury InnovationsMay 16, 2016HiFiBiO SAS announces participation in next generation antibody therapeutics session along with Adimab, F-Star and Innovative Targeting Solutions at BioInternational 2016 in San Francisco, USAMar 23, 2016HiFiBiO is Recognized as an “Innovative Start-up Company” by French President Francois Hollande at the Inauguration of the Institute Pierre-Gilles de GennesNov 23, 2015HiFiBiO SAS to Report Results from the First Fully Integrated, Single-Cell Antibody Discovery Platform at IBC Antibody and Engineering Therapeutics 2015 Conference< 1 … 14 15 16 17 >
